New insights into roles of IL-7R gene as a diagnostic biomarker for post-stroke depression
2024

IL-7R as a Diagnostic Biomarker for Post-Stroke Depression

Sample size: 64 publication 10 minutes Evidence: moderate

Author Information

Author(s): Liu Mengyu, Sun Haochen, Yao Qun, Wang Duohao, Zhang Jihong, Ye Xing, Qi Xinyang

Primary Institution: Affiliated Nanjing Brain Hospital, Nanjing Medical University

Hypothesis

IL-7R levels are lower in post-stroke depression patients compared to post-stroke non-depressed patients due to an overactivated inflammatory response.

Conclusion

IL-7R may serve as a diagnostic marker to distinguish between post-stroke depression and post-stroke non-depressed patients.

Supporting Evidence

  • IL-7R expression levels were significantly lower in MDD patients than in controls.
  • IL-7R had a good diagnostic and predictive effect on MDD and IS patients.
  • The study identified 394 key genes involved in both post-stroke depression and major depression.

Takeaway

This study found that a protein called IL-7R can help doctors tell if someone is feeling sad after a stroke, which can help them get better treatment.

Methodology

The study analyzed gene expression data from two GEO datasets and used various bioinformatics tools to identify differentially expressed genes and their diagnostic potential.

Potential Biases

Potential biases may arise from the selection of datasets and the specific patient populations studied.

Limitations

A larger sample size is needed for validation, and further studies are required to confirm the prognostic value of IL-7R.

Participant Demographics

Participants were aged 40-70 years, including patients with major depression and controls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1506214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication